Clinical Trial Update: Stem Cell Factor Medication for Aplastic Anemia [Phase 1]

View source ↗

Summary

A National Heart, Lung, and Blood Institute-sponsored Phase 1 trial evaluating a stem cell factor medication for aplastic anemia and pancytopenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Pancytopenia

Drugs mentioned

• Stem Cell Factor Medication (Stem cell factor)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Aplastic Anemia, Pancytopenia | Phase 1 | Status: COMPLETED